echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > J Pediatr Hematol Oncol: Diagnosis of invasive fungal infections in children with tumors.

    J Pediatr Hematol Oncol: Diagnosis of invasive fungal infections in children with tumors.

    • Last Update: 2020-10-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Diagnosis of invasive fungal infections (IFI) in the lungs of children with cancer is challenging.
    consensus criteria developed in 2008 state that bronch pipe ablister irrigation (BAL) results cannot be diagnosed.
    video-assisted thoracic laparoscopic pulmonary biopsy (VATS-biopsy) has been increasingly used to assist in the assessment of these children's IFIs.
    retrospective analysis to assess the impact of BAL and VATS-biopsy results on IFI management in children with cancer patients, the results of which were published online in J Pediatr Hematol Oncol.
    study was included in an independent children's hospital for all oncology patients who received VATS-biopsies and/or BAL assessments within 9 years.
    results are management changes in the use of antifellar therapy based on diagnostic procedures, fungal culture results, lung imaging and serological markers.
    results, a total of 102 patients received 122 IFI diagnostic evaluations.
    91 job evaluations included only BAL, 17 involved VATS-biopsy and 14 included both BAL and VATS-biopsy.
    rate of VATS-biopsy (38.7%) was better than that of BAL (27.6%).
    in 14 cases with simultaneous VATS-biopsies and BAL tests, the results were poor.
    of the work, 12 children were confirmed as IFI, 29 were likely and 52 were likely.
    3 times more likely to continue antifellar treatment in patients with a high risk of IFI, and 12.7 times more likely to be confirmed.
    , the results suggest that VATS-biopsy may be a more useful diagnostic aid in IFI diagnosis in children with immunodeficiency on the basis of low BAL diagnosis rates.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.